MedPath

Primary Immunodeficiencies in Costa Rican Adults

Completed
Conditions
Primary Immune Deficiency in Adults
Registration Number
NCT04963660
Lead Sponsor
Caja Costarricense de Seguro Social
Brief Summary

Primary immunodeficiencies represent a underdiagnosed group of rare diseases which if diagnosed well and in time can be treated in an efficient manner and prevent complications that may affect the quality of patients life in an severe manner. Neither in Costa Rica nor in Central America studies or national registries regarding the prevalence and characterization of primary immunodeficiencies in adult patients exist up to now. This study reflects for the first time the epidemiologic situation of primary immunodeficiencies in a Central American country, characterizing adult patients diagnosed with primary and idiopathic immune disorders treated in two specialized immunodeficiency clinics in Costa Rica.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
137
Inclusion Criteria
  • All patients from adult primary immunodeficiency clinics will be included.
Exclusion Criteria
  • Patients with HIV
  • Proven secondary immunodeficiencies.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Clinical manifestations of all adult patients diagnosed with primary and idiopathic immune defects1 year

Describe the clinical manifestations of all adult patients diagnosed with primary and idiopathic immune defects attended in the primary immunodeficiency clinics of the Hospitals Mexico and Dr. Rafael Ángel Calderón Guardia during the study period.

Secondary Outcome Measures
NameTimeMethod
Concordances between clinical manifestations and literature1 year

•Establish concordances between the clinical manifestations of the group of patients under study with those described in the literature according to the different pathologies.

organic complications1 year

Record organic complications secondary to immunodeficiency status.

characterization of immunodeficient patients1 year

Characterize immunodeficient patients using sociodemographic and health variables.

type and degree of immunodeficiency1 year

Differentiate the type and degree of immunodeficiency of each patient.

pathonges that cause infectious1 year

Report isolated pathogens that cause infectious manifestations in patients.

bacteria present in upper airways1 year

•Report the colonizing bacteria present in the cultures of the upper airways of the patients requested in the initial approach.

Trial Locations

Locations (1)

Hospital Calderon Guardia

🇨🇷

San José, Costa Rica

© Copyright 2025. All Rights Reserved by MedPath